Podcast: Thermo Fisher On Challenges Getting Oncomine Dx Approval
Citeline Podcasts - A podcast by Citeline
Categories:
US FDA recently approved the first multi-drug next generation sequencing test made by Thermo Fisher Scientific called Oncomine Dx Target Test. The test is a companion diagnostic for lung cancer drugs made by Novartis, Pfizer and AstraZeneca, and the diagnostic company is looking to expand their partnership to other pharma companies. Medtech Insight chatted with Joydeep Goswami, president of Thermo Fisher’s Clinical Sequencing Division for this podcast.
